Dubuque Bank & Trust CO Edwards Lifesciences Corp Transaction History

Dubuque Bank & Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 21, 2020	SELL	$52.41 - $81.0 $54,034 - $83,511	-1,031 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$71.7 - $82.09 $73,922 - $84,634	1,031 New	1,031 $241,000
Q2 2019 Jul 10, 2019	SELL	$55.74 - $64.41 $48,438 - $55,972	-869 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$47.89 - $64.05 $24,040 - $32,153	-502 Reduced 36.62%	869 $166,000
Q4 2018 Jan 15, 2019	BUY	$46.41 - $56.94 $26,268 - $32,228	566 Added 70.31%	1,371 $210,000
Q3 2018 Oct 30, 2018	SELL	$45.7 - $58.03 $365 - $464	-8 Reduced 0.98%	805 $140,000
Q1 2018 May 10, 2018	BUY	$37.19 - $47.45 $297 - $379	8 Added 0.99%	813 $113,000
Q4 2017 Feb 06, 2018	BUY	$33.79 - $39.39 $22,132 - $25,800	655 Added 436.67%	805 $91,000
Q3 2017 Oct 13, 2017	BUY	$36.29 - $38.83 $5,443 - $5,824	150	150 $16,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Dubuque Bank & Trust CO with notifications on news.